| 摘要 |
<p>Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows: wherein Y, r, R2 and Z are defined herein.</p> |
| 申请人 |
JANSSEN PHARMACEUTICA NV |
发明人 |
CHEVALIER, KRISTEN M.;DAX, SCOTT L.;FLORES, CHRISTOPHER M.;LIU, LI;MACIELAG, MARK J.;MC DONNELL, MARK E.;NELEN, MARINA I.;PROUTY, STEPHEN;TODD, MATTHEW;ZHANG, SUI-PO;ZHU, BIN;NULTON, ERICA L.;CLEMENTE, JOSE |
